Related references
Note: Only part of the references are listed.HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice
Simona Vertuani et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells
Christine Sers et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma
Y. Mizukami et al.
BRITISH JOURNAL OF CANCER (2008)
Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation
Ninke Leffers et al.
GYNECOLOGIC ONCOLOGY (2008)
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy
Takako Suda et al.
CANCER SCIENCE (2007)
HER2, TOP2A, CCND1, EGFR and c-MYC oncogene amplification in colorectal cancer
Khawla Al-Kuraya et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Interferon-γ renders tumors that express low levels of Her-2/neu sensitive to cytotoxic T cells
BLF Kaplan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis
NFS Watson et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma
K Mimura et al.
BRITISH JOURNAL OF CANCER (2005)
Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes
K Kono et al.
CLINICAL CANCER RESEARCH (2004)
Signal transduction and oncogenesis by ErbB/HER receptors
MD Marmor et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway
F Herrmann et al.
CANCER RESEARCH (2004)
Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus
S Ishikura et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Status of c-erbB-2 in gastric adenocarcinoma:: A comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay
T Takehana et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) trial (JCOG9407)
K Hayashi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2001)
MHC class I negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in R0M0 breast cancer patients
A Zia et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Immunization with a HER-2/neu helper peptide generates HER-2/neu CD8 T-cell immunity in cancer patients
KL Knutson et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
